P3 Health Partners (PIII) had the highest return between April 3, 2023 and May 30, 2023 by a mid-cap US stock, returning 270.2%.
| ASSET | DATE | % RETURN |
|---|---|---|
P3 Health Partners (PIII) | 4/3/2023 - 5/30/2023 | 270.18% |
Soleno Therapeutics (SLNO) | 4/3/2023 - 5/30/2023 | 155.71% |
D-Wave Quantum (QBTS) | 4/3/2023 - 5/30/2023 | 99.15% |
Upstart Holdings (UPST) | 4/3/2023 - 5/30/2023 | 85.29% |
IONQ (IONQ) | 4/3/2023 - 5/30/2023 | 75.28% |
TG Therapeutics (TGTX) | 4/3/2023 - 5/30/2023 | 69.82% |
Amneal Pharmaceuticals, Inc Class A Common Stock (AMRX) | 4/3/2023 - 5/30/2023 | 69.5% |
CleanSpark (CLSK) | 4/3/2023 - 5/30/2023 | 65.56% |
Avepoint (AVPT) | 4/3/2023 - 5/30/2023 | 57.21% |
Nuvalent (NUVL) | 4/3/2023 - 5/30/2023 | 56.86% |
Inter & Co Inc Class A Common Shares (INTR) | 4/3/2023 - 5/30/2023 | 46.71% |
Rigetti Computing (RGTI) | 4/3/2023 - 5/30/2023 | 45.07% |
Krystal Biotech (KRYS) | 4/3/2023 - 5/30/2023 | 44.42% |
Crispr Therapeutics (CRSP) | 4/3/2023 - 5/30/2023 | 42.7% |
Arcellx (ACLX) | 4/3/2023 - 5/30/2023 | 42.53% |
Powell Industries (POWL) | 4/3/2023 - 5/30/2023 | 38.54% |
Green Brick Partners (GRBK) | 4/3/2023 - 5/30/2023 | 38.5% |
Crinetics Pharmaceuticals (CRNX) | 4/3/2023 - 5/30/2023 | 37.98% |
SkyWest (SKYW) | 4/3/2023 - 5/30/2023 | 37.86% |
Crane NXT (CXT) | 4/3/2023 - 5/30/2023 | 37.02% |
Legend Biotech (LEGN) | 4/3/2023 - 5/30/2023 | 35.94% |
Dream Finders Homes (DFH) | 4/3/2023 - 5/30/2023 | 35.4% |
Immunitybio (IBRX) | 4/3/2023 - 5/30/2023 | 35.33% |
Immunovant (IMVT) | 4/3/2023 - 5/30/2023 | 34.82% |
Joby Aviation (JOBY) | 4/3/2023 - 5/30/2023 | 33.96% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
